CNBC Stock Blog
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- 9 Stocks That Play Rising Water Costs: Strategists
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Rally Could 'Have Some Legs in 2010': Market Strategist
- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- HP to Feed on Enterprise Spending Next Year: Tech Analyst
- How Stock Investors Can Play Holiday Travel
- 3 Growth Opportunities in Tech: Analyst
- Prep Your Portfolio for Next Week: Stock Pickers
- Global Growth Good for Portfolio: Stock Picker
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Wave of Debt Payments Facing US Government
- HP Comes in As Expected; Is It Time to Buy?
- Why Amazon Rules Retail
- Hewlett-Packard Profit Rises, Matches Guidance
- JAL Slides to Record Low on Bankruptcy Jitters
- Prepare For Large Decline In Stocks, Next Year?
- Paul: Audit the Fed
- The Social Media Gaming Threat
- Holiday Travel Outlook
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- HP's Mark Hurd
- HP Comes in As Expected; Is It Time to Buy?
- 9 Stocks That Play Rising Water Costs: Strategists
- Weis' Deal Likely Won't Change Big Money Contracts
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Nov. 23: Unusual Volume Leaders
- Help Wanted—Please Run $4 Billion University
- Apple Comes to AT&T's Rescue
- Obama says Boosting US Jobs is Top Priority
- More Consumers Giving 'Black Friday' the Cold Shoulder
- Prepare For Large Decline In Stocks, Next Year?
- Hewlett-Packard Earnings Rise, Match Guidance
- HP Comes in As Expected; Is It Time to Buy?
- Cramer: What Monday’s Housing Number Really Means
- Why the Dollar Will Likely Stay Weak for Some Time
- Bear, Lehman Execs Weren't Wiped Out by Crisis: Study
- How Real Estate Investors Skew Housing's Reality
RSS FEED
Text Size 
CNBC News Associate
Are there any buying opportunities for investors on the horizon? Jeffrey Saut, chief investment strategist at Raymond James, and Douglas Cliggott, chief investment officer at Dover Management, shared their market oulooks.
“We’re in the process of making a short-term top here and we’ll get a pullback—but it’s a buy on that pullback,” Saut told CNBC. “And I think we’ll end up higher by year-end.”
However, Saut said he is more worried about 2010 than between now and the end of the year.
In the meantime, Cliggott said the Federal Reserve’s decision to extend its asset-buying program into 2010 will determine how the markets act.
“It’s not a surprise—[The Fed is] not buying Treasurys and suddenly the market isn’t moving anymore,” he said.
Cliggott said investors should look into opportunities in the utilities and pharmaceuticals area.
Counterpoint:
______________________________
Disclosure:
No immediate information was available for Cliggott or Saut.
______________________________
CNBC Slideshows:
______________________________
______________________________
Top Pharmaceutical Companies:
Pfizer [PFE
Loading...
()
]
Johnson & Johnson [JNJ
Loading...
()
]
Merck [MRK
Loading...
()
]
AstraZeneca [AZN
Loading...
()
]
Bristol-Myers Squibb [BMY
Loading...
()
]
______________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes